Country-Specific Pharmacovigilance Requirements
A
Albania
Andorra
Antigua and Barbuda
B
The Bahamas
Belize
Benin
Burkina Faso
Burundi
C
Cabo Verde
Central African Republic
Chad
Comoros
Congo
Côte d’Ivoire
D
Djibouti
Dominica
E
East Timor (Timor-Leste)
El Salvador
Equatorial Guinea
Eritrea
Eswatini
F
Fiji
G
Gabon
Georgia
Grenada
Guinea
Guinea-Bissau
Guyana
H
Haiti
Honduras
I
Iraq
J
K
Kiribati
North Korea
Kyrgyzstan
L
Laos
Lesotho
Liberia
Libya
Liechtenstein
M
Maldives
Mali
Marshall Islands
Mauritania
Micronesia
Moldova
Monaco
Montenegro
Mozambique
Myanmar (Burma)
N
Nauru
Nicaragua
Niger
O
P
Palau
Panama
Papua New Guinea
Q
Qatar
R
S
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Seychelles
Sierra Leone
Solomon Islands
Suriname
Syria
T
Tajikistan
Togo
Tonga
Trinidad and Tobago
Turkmenistan
Tuvalu
U
V
Vanuatu
Vatican City
Y
Yemen
Z